Abstract
Biomarkers are characteristic biological indicators that are used to identify (indirect changes) physical damage or disorders of physiological processes in humans or animals. The potentials they have for detection, diagnostics, prognostics, and intervention direction is crucial in the field of trauma, injury critical care, and recovery. From the last decade of the twentieth century onwards, researchers and clinicians have identified and introduced an increasing number of biomarkers into everyday use. This chapter presents various definition, classifications, and utilization of biomarkers in trauma, injury critical care, and recovery. The current conceptual status of biomarkers both in the field of clinical and diagnostic assessment, more specifically in trauma, injury critical care, and recovery, is presented through the roll of both tools and outcomes in clinical practice and research with the final aim of providing a valid frame for interpretation of clinical states and research questions that rely significant on such biomedical measures. As modern biomedicine uses biomarkers and their presence both as primary outcomes in clinical trials and practice, and this is now a widely accepted and highly appreciated trend, this chapter also covers the overlaps and differences between clinical outcomes and biomarkers. Finally, the chapter presents the role of biomarkers in the process of management of disease that is of highest importance for trauma, injury critical care, and recovery. Although we use biomarkers extensively in clinical practice, our knowledge in this field is quite limited. Thus, further research in this area is needed to confirm the current findings and detect more useful biomarkers.
Abbreviations
- AFP:
-
Alpha fetoprotein
- ALI:
-
Acute lung injury
- ALP:
-
Alanine aminotransferase
- ALS:
-
Alkaline phosphatase
- AST:
-
Aspartate aminotransferase
- BMP-2:
-
Bone morphogenetic protein 2
- BNP:
-
B-type natriuretic peptide
- CA 125:
-
Cancer antigen 125
- CC16:
-
Club cell secretory protein 16
- CEA:
-
Carcinoembryonic antigen
- CK-BB:
-
Creatine kinase brain biomarker
- CK-MB:
-
Creatine kinase myoglobin binding
- CRP:
-
C-reactive protein
- CSF:
-
Cerebrospinal fluid
- cTnI:
-
Cardia Troponin I
- cTnT:
-
Cardia Troponin T
- ESR:
-
Erythrocyte sedimentation rate
- FABP:
-
Fatty acid-binding proteins
- GGT:
-
Gamma-glutamyl transferase
- IGFBP7:
-
Insulin-like growth factor-binding protein 7
- IL-10:
-
Interleukin-10
- IL-18:
-
Interleukin-18
- KIM-1:
-
Kidney injury molecule-1
- LDH:
-
Lactic acid dehydrogenase
- MDSCs:
-
Myeloid-derived suppressor cells
- NF-L:
-
Neuro-filament light chain
- NGAL:
-
Neutrophil gelatinase-associated lipocalin
- NT-proBNP:
-
N-terminal proBNP
- PCT:
-
Procalcitonin
- PSA:
-
Prostate-specific antigen
- S100A8/9:
-
Calprotectin
- SPD:
-
Surfactant protein D
- TIMP-2:
-
Tissue inhibitor of metalloproteinase 2
- VEGF:
-
Vascular endothelial growth factor
- WBC:
-
White blood cell
References
Abidi K, Belayachi J, Derras Y, Khayari ME, Dendane T, Madani N, et al. Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med. 2011;37(7):1136–42.
Adrian H, Mårten K, Salla N, Lasse V. Biomarkers of traumatic brain injury: temporal changes in body fluids. eNeuro. 2016;3(6)
Ahmed S, Venigalla H, Mekala HM, Dar S, Hassan M, Ayub S. Traumatic brain injury and neuropsychiatric complications. Indian J Psychol Med. 2017;39(2):114–21. https://doi.org/10.4103/0253-7176.203129. PMID: 28515545; PMCID: PMC5385737.
Anjum S. Systematic approach to acute cardiovascular emergencies. In: Alsheikhly AS, editor. Essentials of accident and emergency medicine [Internet]. London: IntechOpen; 2018. [cited 2022 Feb 10]. Available from: https://www.intechopen.com/chapters/60421. https://doi.org/10.5772/intechopen.74682.
Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806–15.
Aydin S, Ugur K, Aydin S, Sahin İ, Yardim M. Biomarkers in acute myocardial infarction: current perspectives. Vasc Health Risk Manag. 2019;15:1–10.
Brennan PN, Cartlidge P, Manship T, Dillon JF. Guideline review: EASL clinical practice guidelines: drug-induced liver injury (Dili). Frontline Gastroenterology. 2021;
Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz-Arrastia R. Fluid biomarkers of traumatic brain injury and intended context of use. Diagnostics. 2016;6(4):37.
Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine. Int J Mol Sci. 2019;12:20(8).
Capocchi G, Tassi C, Ricci S, Zampolini M, Fausti R, Rossi A. Creatine kinase BB activity in serum of patients with acute stroke: correlation with the severity of brain damage. Ital J Neurol Sci. 1987;8:567.
Cheung H, Chen N-J, Cao Z, Ono N, Ohashi PS, Yeh W-C. Accessory protein-like is essential for il-18-mediated signaling. J Immunol. 2005;174(9):5351–7.
Chmurzyńska A. The multigene family of fatty acid-binding proteins (fabps): function, structure and polymorphism. J Appl Genet. 2006;47(1):39–48.
Cooper J, Stukas S, Hoiland RL, Fergusson NA, Thiara S, Foster D, et al. Quantification of neurological blood-based biomarkers in critically ill patients with coronavirus disease 2019. Crit Care Explor. 2020;2(10)
Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008;27(3):328–39.
Dessing MC, Tammaro A, Pulskens WP, Teske GJ, Butter LM, Claessen N, et al. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int. 2015;87(1):85–94.
Diamandis EP, Bast RC, Gold P, Chu TM, Magnani JL. Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9. Clin Chem. 2013;59(1):22–31.
Ewaschuk JB, Naylor JM, Zello GA. D-lactate in human and ruminant metabolism. J Nutr. 2005;135:1619–25.
Feldman C. Faculty opinions recommendation of effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. 2018;
Giacoppo S, Bramanti P, Barresi M, Celi D, Foti Cuzzola V, Palella E, et al. Predictive biomarkers of recovery in traumatic brain injury. Neurocrit Care. 2012;16(3):470–7.
Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10(5):1033–43.
Gollin G, Marks C, Marks WH. Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery. 1993;113:545–51.
Hachey BJ, Kontos MC, Christenson RH, Peacock WF, Brewer KC, McCord J. Trends in use of biomarker protocols for the evaluation of possible myocardial infarction. J Am Heart Assoc. 2017;6(9):e005852.
Hier DB, Obafemi-Ajayi T, Thimgan MS, Olbricht GR, Azizi S, Allen B, et al. Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues. Biomarker Res. 2021;9(1)
Hirsch MS, Watkins J. A comprehensive review of biomarker use in the gynecologic tract including differential diagnoses and diagnostic pitfalls. Adv Anat Pathol. 2019;27(3):164–92.
Ichimura T, Asseldonk EJP, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule–1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Investig. 2008;118(5):1657–68.
Jeschke MG. The hepatic response to thermal injury: is the liver important for postburn outcomes? Mol Med. 2009;15(9–10):337–51. https://doi.org/10.2119/molmed.2009.00005. Epub 2009 Apr 10. PMID: 19603107; PMCID: PMC2710295.
Kawata K, Liu CY, Merkel SF, Ramirez SH, Tierney RT, Langford D. Blood biomarkers for brain injury: what are we measuring? Neurosci Biobehav Rev. 2016;68:460–73.
Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M. Immunosuppression following surgical and traumatic injury. Surg Today. 2010;40(9):793–808.
Kolambkar YM, Dupont KM, Boerckel JD, Huebsch N, Mooney DJ, Hutmacher DW, et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials. 2011;32(1):65–74.
Korff S. Differential diagnosis of elevated troponins. Heart. 2006;92(7):987–93.
Lee Y-L, Obiako B, Gorodnya OM, Ruchko MV, Kuck JL, Pastukh VM, et al. Mitochondrial DNA damage initiates acute lung injury and multi-organ system failure evoked in rats by intra-tracheal pseudomonas aeruginosa. Shock. 2017;48(1):54–60.
Lin C-K, Lin Y-H, Huang T-C, Shi C-S, Yang C-T, Yang Y-L. VEGF mediates fat embolism-induced acute lung injury via VEGF receptor 2 and the MAPK CASCADE. Sci Rep. 2019;9(1)
Lin J, Zhang W, Wang L, Tian F. Diagnostic and prognostic values of club cell protein 16 (CC16) in critical care patients with acute respiratory distress syndrome. J Clin Lab Anal. 2017;32(2)
Lord JM, Midwinter MJ, Chen Y-F, Belli A, Brohi K, Kovacs EJ, et al. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet. 2014;384(9952):1455–65.
Long B, Koyfman A, Gottlieb M. Diagnosis of acute heart failure in the emergency department: an evidence-based review. West J Emerg Med. 2019;20(6):875–84.
Manivannan S, Makwana M, Ahmed AI, Zaben M. Profiling biomarkers of traumatic axonal injury: from mouse to man. Clin Neurol Neurosurg. 2018;171:6–20.
Manonmani M, Kavitha M. Association of serum lactate levels with creatine kinase – MB and lactate dehydrogenase in patients with myocardial infarction. Int J Sci Res. 2021:73–5.
Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. 2004;1(2):182–8.
McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 2016;15:817–28. https://doi.org/10.17179/excli2016-800. PMID: 28337112; PMCID: PMC5318690.
Mitrea C, Bollig-Fischer A, Voichiţa C, Donato M, Romero R, Drăghici S. Detecting qualitative changes in biological systems. Sci Rep. 2020;10(1)
Neumaier M, Braun KF, Sandmann G, Siebenlist S. C-reactive protein in Orthopaedic surgery. Acta Chir Orthop Traumatol Cechoslov. 2015;82(5):327–31.
Papa L, Ramia MM, Edwards D, Johnson BD, Slobounov SM. Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion. J Neurotrauma. 2015;32(10):661–73.
Parker AM, Sinha P, Needham DM. Biological mechanisms of cognitive and physical impairments after critical care. Rethinking the inflammatory model? Am J Respir Crit Care Med. 2021;203(6):665–7.
Paustenbach D, Galbraith D. Biomonitoring and biomarkers: exposure assessment will never be the same. Environ Health Perspect. 2006;114(8):1143–9.
Ramamurthy L. Regulatory considerations for diagnostics and biomarkers of traumatic brain injury. Biomark Traumatic Brain Injury. 2020:23–39.
Santucci CA, Purcell TB, Mejia C. Leukocytosis as a predictor of severe injury in blunt trauma. West J Emerg Med. 2008;9(2):81–5.
Schulak DJ, Rayhack JM, Lippert FG 3rd, Convery FR. The erythrocyte sedimentation rate in orthopaedic patients. Clin Orthop Relat Res. 1982;167:197–202.
Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury – pathophysiological basis and clinical performance. Acta Physiol. 2016;219(3):556–74.
Sewpersad S, Pillay TS. Historical perspectives in clinical pathology: Bence Jones protein – early urine chemistry and the impact on modern day diagnostics. J Clin Pathol. 2020;74(4):212–5.
Shafiq M, Akram M, Nasser M. Acute myocardial infarction. Prof Med J. 2013;20(06):871–5.
Shahim P, Zetterberg H, Tegner Y, Blennow K. Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology. 2017;88(19):1788–94.
Sharples E. Acute kidney injury. Oxford Med Online. 2017;
Siderowf A, Aarsland D, Mollenhauer B, Goldman JG, Ravina B. Biomarkers for cognitive impairment in lewy body disorders: status and relevance for clinical trials. Mov Disord. 2018;33(4):528–36.
Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–700.
Sticova E. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013;19(38):6398.
Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–6.
Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. Serum surfactant proteins a and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162(3):1109–14.
Thelin EP, Zeiler FA, Ercole A, Mondello S, Büki A, Bellander B-M, et al. Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol. 2017;8
Torrealba D, More-Bayona JA, Wakaruk J, Barreda DR. Innate immunity provides biomarkers of health for teleosts exposed to nanoparticles. Front Immunol. 2019;9
Wang S, Chi K, Wu D, Hong Q. Insulin-like growth factor binding proteins in kidney disease. Front Pharmacol. 2021;12
Visser EW, Yan J, van IJzendoorn LJ, Prins MW. Continuous biomarker monitoring by particle mobility sensing with Single Molecule Resolution. Nat Commun. 2018;9(1)
Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol. 2013;9(4):201–10.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this chapter.
Author Contributions
JM and DS conceived the chapter and discussed the keyword for literature search. JM was responsible for curating the data. Both authors contributed to composing of the chapter. JM wrote the first draft of the chapter and figures. Both authors assisted in revising the manuscript.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Milic, J., Stankic, D. (2023). A Synopsis of Routine Blood Biomarkers in Trauma, Injury Critical Care and Recovery: General Overview. In: Rajendram, R., Preedy, V.R., Patel, V.B. (eds) Biomarkers in Trauma, Injury and Critical Care. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Cham. https://doi.org/10.1007/978-3-030-87302-8_1-2
Download citation
DOI: https://doi.org/10.1007/978-3-030-87302-8_1-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-87302-8
Online ISBN: 978-3-030-87302-8
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
A Synopsis of Routine Blood Biomarkers in Trauma, Injury Critical Care and Recovery: General Overview- Published:
- 19 January 2023
DOI: https://doi.org/10.1007/978-3-030-87302-8_1-2
-
Original
A Synopsis of Routine Blood Biomarkers in Trauma, Injury Critical Care and Recovery: General Overview- Published:
- 23 July 2022
DOI: https://doi.org/10.1007/978-3-030-87302-8_1-1